Eve BY - Search Results

1

Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-alpha administration.

Dinney CP, Bielenberg DR, Perrotte P, Reich R, Eve BY, Bucana CD, Fidler IJ. Dinney CP, et al. Among authors: eve by. Cancer Res. 1998 Feb 15;58(4):808-14. Cancer Res. 1998. PMID: 9485039

2

Isolation and characterization of metastatic variants from human transitional cell carcinoma passaged by orthotopic implantation in athymic nude mice.

Dinney CP, Fishbeck R, Singh RK, Eve B, Pathak S, Brown N, Xie B, Fan D, Bucana CD, Fidler IJ, et al. Dinney CP, et al. J Urol. 1995 Oct;154(4):1532-8. J Urol. 1995. PMID: 7658585

3

Intravesical liposomal muramyl tripeptide phosphatidylethanolamine treatment of human bladder carcinoma growing in nude mice.

Dinney CP, Tanguay S, Bucana CD, Eve BY, Fidler IJ. Dinney CP, et al. Among authors: eve by. J Interferon Cytokine Res. 1995 Jun;15(6):585-92. J Interferon Cytokine Res. 1995. PMID: 7553228

4

Therapy of human transitional cell carcinoma of the bladder by oral administration of the epidermal growth factor receptor protein tyrosine kinase inhibitor 4,5-dianilinophthalimide.

Dinney CP, Parker C, Dong Z, Fan D, Eve BY, Bucana C, Radinsky R. Dinney CP, et al. Among authors: eve by. Clin Cancer Res. 1997 Feb;3(2):161-8. Clin Cancer Res. 1997. PMID: 9815668

5

Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice.

Perrotte P, Matsumoto T, Inoue K, Kuniyasu H, Eve BY, Hicklin DJ, Radinsky R, Dinney CP. Perrotte P, et al. Among authors: eve by. Clin Cancer Res. 1999 Feb;5(2):257-65. Clin Cancer Res. 1999. PMID: 10037173

6

Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer.

Inoue K, Slaton JW, Kim SJ, Perrotte P, Eve BY, Bar-Eli M, Radinsky R, Dinney CP. Inoue K, et al. Among authors: eve by. Cancer Res. 2000 Apr 15;60(8):2290-9. Cancer Res. 2000. PMID: 10786697

7

Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer.

Inoue K, Slaton JW, Eve BY, Kim SJ, Perrotte P, Balbay MD, Yano S, Bar-Eli M, Radinsky R, Pettaway CA, Dinney CP. Inoue K, et al. Among authors: eve by. Clin Cancer Res. 2000 May;6(5):2104-19. Clin Cancer Res. 2000. PMID: 10815938

8

Adenoviral mediated interferon-alpha 2b gene therapy suppresses the pro-angiogenic effect of vascular endothelial growth factor in superficial bladder cancer.

Adam L, Black PC, Kassouf W, Eve B, McConkey D, Munsell MF, Benedict WF, Dinney CP. Adam L, et al. J Urol. 2007 May;177(5):1900-6. doi: 10.1016/j.juro.2007.01.003. J Urol. 2007. PMID: 17437845

9

The vascular-targeting fusion toxin VEGF121/rGel inhibits the growth of orthotopic human bladder carcinoma tumors.

Mohamedali KA, Kedar D, Sweeney P, Kamat A, Davis DW, Eve BY, Huang S, Thorpe PE, Dinney CP, Rosenblum MG. Mohamedali KA, et al. Among authors: eve by. Neoplasia. 2005 Oct;7(10):912-20. doi: 10.1593/neo.05292. Neoplasia. 2005. PMID: 16242074 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters